SPL 1.03% 9.8¢ starpharma holdings limited

Key Opinion Leader Jack Sobel

  1. 12,941 Posts.
    lightbulb Created with Sketch. 1456
    fyi





    Special Issue "Bacterial Vaginosis - Existing Challenges to Successful Therapy"


    A special issue of Pathogens (ISSN 2076-0817).
    Deadline for manuscript submissions: 30 September 2022.

    Share This Special Issue


    mce-anchorSpecial Issue Editors

    Prof. Dr. Jack Sobel E-Mail Website
    Guest Editor

    Internal Medicine Unit, Wayne State University School of Medicine, Detroit, MI, USA
    Interests: internal medicine; immunology and microbiology; obstetrics and gynecology
    Prof. Dr. Christina Muzny E-Mail Website
    Guest Editor

    Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
    Interests: pathogenesis; epidemiology; diagnosis, treatment, and prevention of bacterial vaginosis and trichomoniasis
    mce-anchorSpecial Issue Information

    Dear Colleagues,
    Bacterial vaginosis (BV), the most common cause of vaginal infection worldwide, continues to provide multiple major challenges to successful treatments and cures. Progress is handicapped by multiple areas of poor and inadequate understanding of the pathogenesis of BV. The clinical syndrome clearly encases a variable microbiota both qualitatively and quantitatively, hence the frequently unpredictable clinical course, prognosis, and response to antimicrobial therapy. So many questions remain unanswered. Although diagnostic modalities have progressed from useful but highly subjective criteria (Amsel) to less subjective microscopy (Nugent) and quantitative molecular methods including PCR and next generation sequencing that allow commercial access, the data generated still beg more questions than ever and enhance the complexity of this syndrome. Each year we add to the list of consequences and complications of BV in gravid and non-gravid females alike. However, it is in the realm of therapy that we sadly lag, fueled by a continued lack of a clear understanding of pathophysiology and, not surprisingly, by a continued empty therapeutic pipeline. Frustration continues to dominate modern referral clinics, which is evident in patients and practitioners alike. The proposed Special Issue will highlight and target these many deficiencies while focussing on the unacceptably high recurrence rate of symptomatic disease and, in the absence of available antimicrobials, review treatment strategies.
    Prof. Dr. Jack Sobel
    Prof. Dr. Christina Muzny


    https://www.infectiousdiseaseadviso...cine/infectious-diseases/bacterial-vaginosis/

    preprints202203.0042.v1.pdf
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.8¢
Change
0.001(1.03%)
Mkt cap ! $40.97M
Open High Low Value Volume
9.7¢ 9.9¢ 9.7¢ $44.76K 455.2K

Buyers (Bids)

No. Vol. Price($)
1 824859 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 121525 5
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.